CODEXIS INC. - COMMON STOCK

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

18 Sep 2023 16:05:42 By Nasdaq GlobeNewswire

Codexis to Participate in Cantor Global Healthcare Conference

12 Sep 2023 16:05:58 By Nasdaq GlobeNewswire

Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease

07 Sep 2023 16:05:19 By Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2023 Financial Results

03 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics

31 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026

20 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces New Employment Inducement Grants

09 Jun 2023 16:05:09 By Nasdaq GlobeNewswire

Codexis to Participate in Jefferies Healthcare Conference

24 May 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA

10 May 2023 16:05:01 By Nasdaq GlobeNewswire

Codexis Announces New Employment Inducement Grants

08 May 2023 16:05:41 By Nasdaq GlobeNewswire

Codexis Reports First Quarter 2023 Financial Results

04 May 2023 16:05:02 By Nasdaq GlobeNewswire

Codexis to Report First Quarter 2023 Financial Results on May 4

20 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA

19 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces New Employment Inducement Grants

06 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors

04 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces New Employment Inducement Grants

09 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Cowen 43rd Annual Health Care Conference

27 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results

23 Feb 2023 16:06:00 By Nasdaq GlobeNewswire

Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

23 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™

22 Feb 2023 16:05:21 By Nasdaq GlobeNewswire